Skip to content
Home/Companies/Biotech/Carisma Therapeutics

Carisma Therapeutics

Biotech·US·Exited 2023·Held 5yr
Entry
2018
Hold
5yr
Exit
2023

Who owns Carisma Therapeutics?

Carisma Therapeutics was owned by HealthCap through HealthCap VII (2016 vintage) from 2018 to 2023, exited via IPO. Across its history, Carisma Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-10

HealthCap
Most recent investor
HealthCap
HealthCap VII · 2016 · VC
2 ownership periods · full history below

Key facts

HQUnited States
SectorBiotech
StatusAcquired
Key takeaways
  • ·Fully exited in 2023.
  • ·Average hold across 2 realized cycles: 5 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2023.
Co-invest · 2 holders · 2018 · 2023
Wellington Partners
2018 · 2023(5yr) · Wellington Partners Life Sciences · 1998 · VC
IPO
MOIC
–
HealthCap
HealthCapExited 2023
2018 · 2023(5yr) · HealthCap VII · 2016 · VC
IPO · to
MOIC
–
Track Carisma Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Carisma Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Carisma Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue